company background image
X2S logo

Sinopharm Group DB:X2S Stock Report

Last Price

€2.39

Market Cap

€7.5b

7D

-0.8%

1Y

-11.8%

Updated

27 Mar, 2024

Data

Company Financials +

X2S Stock Overview

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China.

X2S fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends5/6

Sinopharm Group Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinopharm Group
Historical stock prices
Current Share PriceHK$2.39
52 Week HighHK$3.25
52 Week LowHK$2.02
Beta0.84
1 Month Change-6.65%
3 Month Change1.27%
1 Year Change-11.76%
3 Year Change15.78%
5 Year Change-35.71%
Change since IPO35.51%

Recent News & Updates

Recent updates

Shareholder Returns

X2SDE HealthcareDE Market
7D-0.8%-3.2%1.9%
1Y-11.8%-1.8%7.3%

Return vs Industry: X2S underperformed the German Healthcare industry which returned -1.8% over the past year.

Return vs Market: X2S underperformed the German Market which returned 7.3% over the past year.

Price Volatility

Is X2S's price volatile compared to industry and market?
X2S volatility
X2S Average Weekly Movement6.9%
Healthcare Industry Average Movement5.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: X2S has not had significant price volatility in the past 3 months.

Volatility Over Time: X2S's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003115,959Yong Liuhttps://www.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.

Sinopharm Group Co. Ltd. Fundamentals Summary

How do Sinopharm Group's earnings and revenue compare to its market cap?
X2S fundamental statistics
Market cap€7.52b
Earnings (TTM)€1.16b
Revenue (TTM)€76.24b

6.5x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
X2S income statement (TTM)
RevenueCN¥596.57b
Cost of RevenueCN¥548.06b
Gross ProfitCN¥48.51b
Other ExpensesCN¥39.46b
EarningsCN¥9.05b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.90
Gross Margin8.13%
Net Profit Margin1.52%
Debt/Equity Ratio57.0%

How did X2S perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

30%

Payout Ratio

Does X2S pay a reliable dividends?

See X2S dividend history and benchmarks
When do you need to buy X2S by to receive an upcoming dividend?
Sinopharm Group dividend dates
Ex Dividend DateJun 17 2024
Dividend Pay DateAug 13 2024
Days until Ex dividend81 days
Days until Dividend pay date138 days

Does X2S pay a reliable dividends?

See X2S dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.